Accelerating vaccine development through operational excellence

The warp-speed approach required to discover, develop, and deliver new tools to end the COVID pandemic cannot be sustained, and yet the pace needed to efficiently test novel vaccines in large, representative trials remains extremely fast. What have we learned and what are we doing differently to enable this?

In this webinar, join Anne Kasmar, MD, MSc, and Leslie Johnston, veteran clinical trial operations leader as we share our insights into achieving sustainable speed at scale. 


Return to Insights Center